Scholarlink

Background <p>Phenylketonuria (PKU) is one of the common Inborn Errors of Metabolism diseases, that is caused by a phenylalanine hydroxylase (PAH) deficiency or cofactor tetrahydrobiopterin. This systematic review and meta-analysis aimed to investigate the prevalence of PKU in Iran.</p> Methods <p>The protocol was registered in PROSPERO (CRD42024540811). The MOOSE protocol and the PRISMA guidelines were used. The Web of Sciences, PubMed/ Medline, Sciences Direct, Google Scholar, Scopus, Civilica, IranDoc, and SID databases were searched on 31/03/2024. The I<sup>2</sup> index and Q test were used to check heterogeneity. Comprehensive meta-analysis software (CMA ver. 2) was used (<i>P</i> &lt; 0.05 is considered significant). The prevalences were reported in 100,000 neonates at national and provincial levels.</p> Results <p>Finally, 20 studies with 1,992,090 Iranian neonates were included. The prevalence of screen-positive cases was 75.6 (95% CI: 48.1–118.72). The prevalence of confirmed PKU was 16.7 (95% CI: 13.6– 20.5); this prevalence in girls and boys was 15.2 (95% CI: 5.2–44.2) and 9.8 (95% CI: 3.2– 29.8), respectively. 53% of the cases had Hyperphenylalaninemia (HPA). The prevalence of HPA and classical PKU was estimated at 8.9 (95% CI: 5.9–13.41) and 8.0 (95% CI: 5.1–12.59), respectively. Subgroup analysis was performed based on region, province, and study quality to discover the source of heterogeneity. In addition, mixed effects meta-regression was used to find the relationship between continuous variables. Sensitivity analysis showed that the pooled estimate was robust.</p> Conclusions <p>It seems that the screening program in Iran was effective and detected almost all PKU cases in the first few days of their lives. This information showed that the PKU prevalence is relatively higher than in most parts of the world, thus their prevalence should be controlled.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The prevalence of phenylketonuria (PKU) and hyperphenylalaninemia (HPA) in Iran: a systematic review and meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月25日

查看全文
  • Samira Faraji,
  • Seyed Mohammad Tabatabaee Jabali,
  • Mohammad Hasan Abolhasani,
  • Davoud Amirkashani,
  • AliAkbar Haghdoost,
  • Mahdi Shadnoush,
  • Saeedeh Talebi,
  • Golnaz Ranjbar,
  • Saeid Talebi,
  • Maryam Mahmoudi,
  • Peyman Eshraghi,
  • Tayebeh Najafimoghadam,
  • Bahareh Lesani Gouya,
  • Mohsen Nematy,
  • Abdolreza Norouzy

摘要

Background

Phenylketonuria (PKU) is one of the common Inborn Errors of Metabolism diseases, that is caused by a phenylalanine hydroxylase (PAH) deficiency or cofactor tetrahydrobiopterin. This systematic review and meta-analysis aimed to investigate the prevalence of PKU in Iran.

Methods

The protocol was registered in PROSPERO (CRD42024540811). The MOOSE protocol and the PRISMA guidelines were used. The Web of Sciences, PubMed/ Medline, Sciences Direct, Google Scholar, Scopus, Civilica, IranDoc, and SID databases were searched on 31/03/2024. The I2 index and Q test were used to check heterogeneity. Comprehensive meta-analysis software (CMA ver. 2) was used (P < 0.05 is considered significant). The prevalences were reported in 100,000 neonates at national and provincial levels.

Results

Finally, 20 studies with 1,992,090 Iranian neonates were included. The prevalence of screen-positive cases was 75.6 (95% CI: 48.1–118.72). The prevalence of confirmed PKU was 16.7 (95% CI: 13.6– 20.5); this prevalence in girls and boys was 15.2 (95% CI: 5.2–44.2) and 9.8 (95% CI: 3.2– 29.8), respectively. 53% of the cases had Hyperphenylalaninemia (HPA). The prevalence of HPA and classical PKU was estimated at 8.9 (95% CI: 5.9–13.41) and 8.0 (95% CI: 5.1–12.59), respectively. Subgroup analysis was performed based on region, province, and study quality to discover the source of heterogeneity. In addition, mixed effects meta-regression was used to find the relationship between continuous variables. Sensitivity analysis showed that the pooled estimate was robust.

Conclusions

It seems that the screening program in Iran was effective and detected almost all PKU cases in the first few days of their lives. This information showed that the PKU prevalence is relatively higher than in most parts of the world, thus their prevalence should be controlled.